Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Ekaterina Trishkina"'
Autor:
Ekaterina Trishkina, Konstantin S. Zadiran, Aleksandr O. Morozov, Alla G. Kravets, Gais Al-Merri
Publikováno v:
Communications in Computer and Information Science ISBN: 9783030297428
In the conditions of modern management of hospitality facilities, the used approaches and tools for resource management play an important role. The article discusses the use of mobile technologies in resource management of the hotel’s housekeeping
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::325e13c9048e535d57ff8ecf3fe3f528
https://doi.org/10.1007/978-3-030-29743-5_17
https://doi.org/10.1007/978-3-030-29743-5_17
Autor:
Matthew J. Ellis, Mary Stuart, Alexey Manikhas, John F.R. Robertson, Mehdi Fazal, Kwok-Leung Cheung, Ekaterina Trishkina, Manuel Ruiz-Borrego, Lynda Grinsted, Lawrence Panasci, Igor Bondarenko, Servando Cardona-Huerta, Manuel Jesus Philco-Salas, M. Dvorkin, Zhimin Shao, Yaroslav Shparyk, Jacqui Rowbottom, Shinzaburo Noguchi
Publikováno v:
The Lancet. 388:2997-3005
Summary Background Aromatase inhibitors are a standard of care for hormone receptor-positive locally advanced or metastatic breast cancer. We investigated whether the selective oestrogen receptor degrader fulvestrant could improve progression-free su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f80f1c578ac32af806bc24cc37b2b9f5
https://doi.org/10.1016/s0140-6736(16)32389-3
https://doi.org/10.1016/s0140-6736(16)32389-3
Autor:
Yuriy Vinnyk, Marek Z. Wojtukiewicz, Yaroslav Shparyk, Xavier Pivot, Jin-Hee Ahn, Maximino De Guzman Bello, Sujeong Song, Vladimir Semiglazov, Zbigniew Nowecki, Sanjoy Chatterjee, Igor Bondarenko, Vladimir Moiseyenko, Seock-Ah Im, Ekaterina Trishkina, Jaeyun Lim, Tomasz Sarosiek, Mikhail Dvorkin
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 36(10)
Purpose This phase III study compared SB3, a trastuzumab (TRZ) biosimilar, with reference TRZ in patients with human epidermal growth factor receptor 2–positive early breast cancer in the neoadjuvant setting ( ClinicalTrials.gov identifier: NCT0214
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a617ccd5cfa3ffdde8e7de18d79122c9
https://pubmed.ncbi.nlm.nih.gov/29373094
https://pubmed.ncbi.nlm.nih.gov/29373094
Autor:
Tomasz Sarosiek, Yaroslav Shparyk, Vladimir Moiseyenko, Seock Ah Im, Maximino De Guzman Bello, Xavier Pivot, Vladimir Semiglazov, Jae Yun Lim, Marek Z. Wojtukiewicz, M. Dvorkin, J.-H. Ahn, Y. Lee, Igor Bondarenko, Ekaterina Trishkina, Zbigniew Nowecki, Sanjoy Chatterjee
Publikováno v:
European journal of cancer (Oxford, England : 1990). 93
Background The equivalent efficacy between SB3, a proposed trastuzumab biosimilar, and the trastuzumab reference product (TRZ) in terms of the breast pathologic complete response rate after neoadjuvant therapy in patients with early or locally advanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49516f0b86f6bc234ba48ba45cbbea65
https://pubmed.ncbi.nlm.nih.gov/29680363
https://pubmed.ncbi.nlm.nih.gov/29680363
Autor:
Marina Matrosova, Kritiya Butthongkomvong, Steen Lindkær-Jensen, Vichien Srimuninnimit, Ekaterina Trishkina, Alexey Manikhas, Elena Poddubuskaya, Stig Larsen
Publikováno v:
Breast Cancer : Targets and Therapy
Stig Larsen,1 Kritiya Butthongkomvong,2 Alexey Manikhas,3 Ekaterina Trishkina,4 Elena Poddubuskaya,5 Marina Matrosova,6 Vichien Srimuninnimit,7 Steen Lindkær-Jensen81Department of Controlled Clinical Trials and Biostatistics, Centre for Epidemiology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05327188b26f224dca05145d39d2c897
http://europepmc.org/articles/PMC4251531
http://europepmc.org/articles/PMC4251531
Autor:
Igor Bondarenko, Tomasz Sarosiek, Marek Z. Wojtukiewicz, Vladimir Moiseyenko, Jae Yun Lim, Ekaterina Trishkina, Mikhail Dvorkin, Zbigniew Nowecki, Xavier Pivot, Younsoo Kim, Yaroslav Shparyk
Publikováno v:
Journal of Clinical Oncology. 36:e12631-e12631
e12631Background: SB3 was approved by the European Commission as a trastuzumab (TRZ) biosimilar. Here, we report safety and survival data with a follow-up of at least 12 treatment-free months after...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b9ff1704b871023350aaf12bf0216aa
https://doi.org/10.1200/jco.2018.36.15_suppl.e12631
https://doi.org/10.1200/jco.2018.36.15_suppl.e12631
Autor:
Ekaterina Trishkina, Kritiya Butthongkomvong, Isaraporn Sangsaikae, Alexey Manikas, Stig Larsen, Marina Matrosova, Sirikul Sorraritchingchai, Elena Poddubuskaya
Publikováno v:
Journal of Clinical Oncology. 35:e12581-e12581
e12581 Background: Cis-coordinated complexes of platinum(II) with polymer of benzene polycarboxylic is currently evaluated in clinical trials for treatment of metastatic breast cancer (MBC) patients. The RECIST was used for evaluation of the target l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::291839f5b88f6d3e3fb2106ede9c5d01
https://doi.org/10.1200/jco.2017.35.15_suppl.e12581
https://doi.org/10.1200/jco.2017.35.15_suppl.e12581
Autor:
Seock-Ah Im, Maximino De Guzman Bello, Sanjay Chattopadhyay, Jae Yun Lim, Vladimir Semiglazov, Igor Bondarenko, Tomasz Sarosiek, Mikhail Dvorkin, Ekaterina Trishkina, Sujeong Song, Yaroslav Shparyk, Marek Z. Wojtukiewicz, Xavier Pivot, Vladimir Moiseyenko, Jin-Hee Ahn
Publikováno v:
Journal of Clinical Oncology. 35:509-509
509 Background: SB3, a proposed biosimilar to the originator trastuzumab (TRZ), demonstrated similarity to its originator in terms of biological activities and pharmacokinetic (PK) equivalence. This study compared SB3 to TRZ in terms of efficacy, saf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::289a95b9132c24d0f4ef63153c50028d
https://doi.org/10.1200/jco.2017.35.15_suppl.509
https://doi.org/10.1200/jco.2017.35.15_suppl.509
Autor:
Yaroslav Shparyk, Mehdi Fazal, Lynda Grinsted, Alexey Manikhas, Lawrence Panasci, J.F.R. Robertson, Z Shao, Kwok-Leung Cheung, M.J. Philco-Salas, Manuel Ruiz-Borrego, Ekaterina Trishkina, M. Dvorkin, I. Bondarenko, Servando Cardona-Huerta, Matthew J. Ellis, Mary Stuart, Shinzaburo Noguchi
Publikováno v:
Annals of Oncology. 27:vi554
Background: This Phase III, randomised, double-blind, multicentre trial (FALCON; NCT01602380) compared the selective estrogen receptor (ER) degrader (SERD) fulvestrant with anastrozole in patients with ER- and/or progesterone receptor-positive locall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27606eb3ec7225ccab09f75138f074ed
https://doi.org/10.1093/annonc/mdw435.04
https://doi.org/10.1093/annonc/mdw435.04
Autor:
Marina Matrosova, Ekaterina Trishkina, Elena Poddubuskaya, Stig Larsen, Alexey Manikhas, Steen Lindkaer Jensen
Publikováno v:
Journal of Clinical Oncology. 33:e12086-e12086
e12086 Background: The aims were to compare the efficacy and tolerability of a new benzene-poly-carboxylic acids complex with cis-diammineplatium (II) (BP-C1) versus equal looking placebo and to in...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee6d6a4db6a8adc12863b7c9ac7b8239
https://doi.org/10.1200/jco.2015.33.15_suppl.e12086
https://doi.org/10.1200/jco.2015.33.15_suppl.e12086